CD40LG and lobular neoplasia: However, investigations of the impact of aPL on renal outcomes in LN have been conflicting, demonstrating associations of aPL with renal function deterioration in some studies [13], no association with long-term renal outcomes in others [14], and even a protective role of IgM anti-β2-GPI against renal damage in a recent report [15].